Measurements fail to identify TB patients who could benefit from shorter treatment course

June 30, 2009

Tuberculosis (TB) is a difficult infection to treat and requires six months of multiple antibiotics to cure it. To combat the TB pandemic, a shorter and simpler drug treatment would be a huge advance since most TB occurs in resource-limited settings with poor public health infrastructures.

Testing whether two simple clinical measurements might help identify which TB patients could benefit from shorter treatment, researchers at Case Western Reserve University and University Hospitals (UH) Case Medical Center report that these measurements failed to work in a study published online by the .

The two measurements were absence of a cavity (an abscess caused by TB) in the lungs (detected by chest X-ray) and failure to grow from the sputum once drug treatment was started (sputum culture conversion). The Phase III clinical trial involved TB patients in Uganda (Africa), Brazil (S. America) and the Philippines (Asia) and was conducted by the Research Unit (TBRU) at Case Western Reserve University and UH Case Medical Center in Cleveland, the only National Institutes of Health supported TB unit in the U.S.

"We found that combining these two clinical measurements failed to select TB patients who could benefit from shorter drug treatment. TB patients receiving four months of TB treatment had their disease come back much more often than those who got six months of drug treatment," said W. Henry Boom, M.D., an infectious disease expert with Case Western Reserve University and UH Case Medical Center and Director of the TBRU. "This study points out the limitations of current clinical measures to identify the relatively small group of TB patients who respond poorly to standard drug treatment."

"To better identify risk factors for why treatment fails in a subset of TB patients will require novel approaches and further research so that we can determine quickly (not having to wait for two years after completing six months of drug treatment to measure relapses) not only the effectiveness of new TB drugs or regimens but also who will benefit most from these shortened and simplified TB treatment regimens," added John L. Johnson, MD, first author of the study and an infectious disease expert with Case Western Reserve University School of Medicine and UH Case Medical Center.

Source: University Hospitals Case Medical Center


   
Rate this story - not rated yet


June 30, 2009 all stories

Comments: 0

not rated yet

  • hide
  • Related Stories

  • Researchers urge integrating TB into HIV care
    created Jul 22, 2008 | popularity not rated yet | comments 0
  • Slow-growing TB bacteria point the way to new drug development
    created Mar 30, 2009 | popularity not rated yet | comments 0
  • WHO warns of drug-resistant TB
    created Sep 06, 2006 | popularity not rated yet | comments 0
  • HIV/AIDS linked to drug resistant TB
    created Nov 16, 2006 | popularity not rated yet | comments 0
  • Extensively drug-resistant tuberculosis found in California
    created Aug 13, 2008 | popularity not rated yet | comments 0



  • hide
  • Relevant PhysicsForums posts

Other News

Early life stress may predict cardiovascular disease

Early life stress may predict cardiovascular disease

Medicine & Health / Health

created 30 minutes ago | popularity not rated yet | comments 0 | with audio podcast

Early life stress could be a risk factor for cardiovascular disease in adulthood, researchers report.


Babies wise to what we really mean: Researchers find first evidence that six-month-olds comprehend adults' intentions

Medicine & Health / Psychology & Psychiatry

created 48 minutes ago | popularity not rated yet | comments 0 | with audio podcast

A study by York University researchers reveals that infants as young as six months old know when we're "playing" them - and they don't like it.


Predicting effectiveness of flu vaccination campaigns

Medicine & Health / Research

created 48 minutes ago | popularity not rated yet | comments 0

A new study, published by Elsevier this month in Vaccine, describes a new method that assesses the impact and cost-effectiveness of a range of vaccination options. The model was applied to the 2009 Influenza H1N1 outbreak and pr ...


Study: End-of-life care must reflect patient wishes and values

Medicine & Health / Health

created 28 minutes ago | popularity not rated yet | comments 0

Researchers from Brown University and Harvard Medical School are calling for improved decision-making in the use of feeding tubes for hospitalized nursing home residents with advanced dementia.


The biggest loser: Maternal obesity puts a load on her offspring that lasts a lifetime

Medicine & Health / Health

created 38 minutes ago | popularity not rated yet | comments 0

As if there are not enough reasons for obese people to lose weight, a new research report published online in The FASEB Journal, adds several more. In a study involving rats, researchers from Duke University found that obesity ...